Skip to main content
Clinical Trials/NCT04934007
NCT04934007RecruitingNot Applicable

A Randomized Control Trial of Bilateral Lateral OFC rTMS in Obsessive Compulsive Disorder

Centre Hospitalier Henri Laborit3 sites in 1 country136 target enrollmentStarted: September 6, 2021Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
136
Locations
3
Primary Endpoint
Yale Brown Obsessive Compulsive Scale score

Study Overview

Brief Summary

According to the literature the lateral part of the Orbito Frontal Cortex (lOFC) is a relevant bilateral target for repetitive Trans-cranial Magnetic Stimulation (rTMS) in Obsessive Compulsive Disorder (OCD). Both hemispheres are concerned in terms of target.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Participant, Investigator)

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Age: Participants will be both males and females, 18-65 years of age included.
  • diagnosis of OCD
  • all the patients must have failed to respond to at least two different pharmacological treatment used for at least 6 weeks
  • Affiliation to a social security system (recipient or assignee),
  • Signed written inform consent form

Exclusion Criteria

  • The exclusion criteria are a diagnosis of another psychiatric disorder (except for anxious disorders), a diagnosis of a significant active medical illness, pregnancy or other neurological illness
  • In accordance with the safety criteria for rTMS, patients with a history of seizure or bearing pacemakers, mobile metal implants, implanted medical pumps, or metal clips placed inside the skull will also be excluded
  • The patients won't be allowed to change their medication during the trial. The treatment must be stable at least 3 week before day
  • Female subject who is pregnant, or of child-bearing age, sexually active and not using reliable contraception or who is nursing,
  • Patient under curators
  • Patient hospitalized under duress
  • Patient unable to give his or hers informed consent

Arms & Interventions

Active stimulation

Experimental

Active rTMS stimulation , 2 session per day during 10 days.

Intervention: rTMS Treatment (Device)

Sham Stimulation

Sham Comparator

Sham rTMS stimulation , 2 session per day during 10 days.

Intervention: rTMS Treatment (Device)

Outcomes

Primary Outcomes

Yale Brown Obsessive Compulsive Scale score

Time Frame: baseline and 25 days

Significant clinical change (≥ 25%) from baseline to two weeks after the treatment sequence, assessed by a significant reduction in YBOCS scores at day 25

Secondary Outcomes

  • general assessement functioning (GAF)(baseline and 70 days)
  • Clinical Global Impression (CGI)(baseline and 70 days)
  • Adverse events linked to the rTMS treatment(70 days)
  • Yale Brown Obsessive Compulsive Scale(baseline and 70 days)
  • general assessement functioning (GAF)(baseline and 25 days)
  • Clinical Global Impression (CGI)(baseline and 25 days)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (3)

Loading locations...

Similar Trials